Association of mild kidney dysfunction with diastolic dysfunction and heart failure with preserved ejection fraction.

Robin W M Vernooij, Anne-Mar L N van Ommen, Gideon B Valstar, Maarten Jan Cramer, Arco J Teske, Roxana Menken, Leo Hofstra, Frans H Rutten, Michiel L Bots, Hester M den Ruijter, Marianne C Verhaar
Author Information
  1. Robin W M Vernooij: Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. ORCID
  2. Anne-Mar L N van Ommen: Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  3. Gideon B Valstar: Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  4. Maarten Jan Cramer: Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  5. Arco J Teske: Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  6. Roxana Menken: Cardiology Centers of the Netherlands, Utrecht, The Netherlands.
  7. Leo Hofstra: Cardiology Centers of the Netherlands, Utrecht, The Netherlands.
  8. Frans H Rutten: Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  9. Michiel L Bots: Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  10. Hester M den Ruijter: Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  11. Marianne C Verhaar: Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Abstract

AIMS: We aim to investigate the association between kidney dysfunction and left ventricular diastolic dysfunction parameters and heart failure with preserved ejection fraction (HFpEF) and whether this is sex-specific.
METHODS AND RESULTS: We included participants from the HELPFul observational study. Outpatient clinical care data, including echocardiography, and an expert panel judgement on HFpEF was collected. Estimated glomerular filtration rate (eGFR) was calculated by creatinine and cystatin C without race. The association between eGFR with E/e', left ventricular mass index, relative wall thickness, and stage C/D heart failure was tested by multivariable adjusted regression models, stratified by sex, reporting odds ratios and 95% confidence intervals (95% confidence interval). We analysed 880 participants, mean age 62.9 (standard deviation: 9.3) years, 69% female. Four hundred six participants had mild (37.6%) kidney dysfunction (eGFR: 60-89 mL/min/1.73 m ) or moderate (8.5%) kidney dysfunction (eGFR: 30-59 mL/min/1.73 m ). HFpEF was significantly more prevalent in participants with mild and moderate kidney dysfunction (10.3% and 16.0%, respectively) than participants with normal kidney function (3.4%). A lower kidney function was associated with higher E/e' and higher relative wall thickness values. Participants with moderate kidney dysfunction had a higher likelihood of American College of Cardiology/American Heart Association stage C/D HF (odds ratio: 2.07, 95% confidence interval: 1.23, 3.49) than participants with normal kidney functions.
CONCLUSIONS: Both mild and moderate kidney dysfunction are independently associated with left ventricular diastolic dysfunction parameters and HFpEF. This association is independent of sex and strongest for moderate kidney dysfunction. Considering mild-to-moderate kidney dysfunction as risk factor for HFpEF may help identify high-risk groups benefiting most from early intervention.

Keywords

References

  1. Cardiovasc Ultrasound. 2012 Mar 19;10:10 [PMID: 22429658]
  2. J Am Soc Echocardiogr. 2016 Apr;29(4):277-314 [PMID: 27037982]
  3. ESC Heart Fail. 2017 Aug;4(3):266-273 [PMID: 28772030]
  4. N Engl J Med. 2020 Nov 5;383(19):1838-1847 [PMID: 32865380]
  5. J Hypertens. 2009 Mar;27(3):633-41 [PMID: 19262231]
  6. Circulation. 2017 Aug 8;136(6):e137-e161 [PMID: 28455343]
  7. PLoS One. 2021 Aug 12;16(8):e0255869 [PMID: 34383841]
  8. N Engl J Med. 2022 Sep 22;387(12):1089-1098 [PMID: 36027570]
  9. Eur Heart J. 2019 Oct 21;40(40):3297-3317 [PMID: 31504452]
  10. Int J Cardiol Heart Vasc. 2020 May 07;28:100525 [PMID: 32420447]
  11. J Am Heart Assoc. 2017 May 2;6(5): [PMID: 28465299]
  12. JAMA. 2013 Jul 3;310(1):66-74 [PMID: 23821090]
  13. Contrib Nephrol. 2013;182:117-36 [PMID: 23689659]
  14. J Card Fail. 2006 Oct;12(8):601-7 [PMID: 17045178]
  15. Contrib Nephrol. 2013;182:137-57 [PMID: 23689660]
  16. Eur Heart J. 2014 Feb;35(7):455-69 [PMID: 24164864]
  17. J Card Fail. 2021 Jul;27(7):756-765 [PMID: 33647474]
  18. Nephrol Dial Transplant. 2014 Nov;29(11):2069-74 [PMID: 24916339]
  19. Eur Heart J. 2005 Jan;26(1):11-7 [PMID: 15615794]
  20. Eur Heart J. 2018 Mar 7;39(10):840-849 [PMID: 29293969]
  21. N Engl J Med. 2021 Nov 4;385(19):1737-1749 [PMID: 34554658]
  22. J Am Soc Nephrol. 2007 Apr;18(4):1307-15 [PMID: 17344421]
  23. Nephrol Dial Transplant. 2012 Feb;27(2):694-700 [PMID: 21613387]
  24. Eur J Clin Invest. 2015 Jan;45(1):18-26 [PMID: 25402558]
  25. JAMA. 2003 Jan 8;289(2):194-202 [PMID: 12517230]
  26. J Nephrol. 2010 Mar-Apr;23(2):181-8 [PMID: 20119930]
  27. Circulation. 2017 Feb 28;135(9):825-838 [PMID: 28039229]
  28. BMJ Open. 2019 Jun 5;9(6):e028408 [PMID: 31171553]
  29. N Engl J Med. 2012 Jul 5;367(1):20-9 [PMID: 22762315]
  30. J Am Soc Nephrol. 2019 Jan;30(1):137-146 [PMID: 30510134]
  31. Am J Epidemiol. 2017 Jun 15;185(12):1221-1227 [PMID: 28453616]
  32. ESC Heart Fail. 2022 Feb;9(1):363-372 [PMID: 34889076]
  33. Clin Exp Hypertens. 2010 Jan;32(2):113-20 [PMID: 20374184]
  34. Nat Rev Cardiol. 2017 Oct;14(10):591-602 [PMID: 28492288]
  35. Eur J Prev Cardiol. 2021 Dec 29;28(15):1650-1661 [PMID: 33624088]
  36. Int J Cardiol. 2015 Dec 1;200:15-9 [PMID: 26404747]
  37. Contrib Nephrol. 2013;182:99-116 [PMID: 23689658]
  38. Contrib Nephrol. 2013;182:158-73 [PMID: 23689661]
  39. Int J Cardiol. 2016 Jul 1;214:301-6 [PMID: 27082778]
  40. Nephron. 1976;16(1):31-41 [PMID: 1244564]
  41. Eur Heart J. 2013 May;34(19):1424-31 [PMID: 23470495]
  42. Int J Nephrol. 2011;2011:153868 [PMID: 21977320]
  43. Eur J Heart Fail. 2012 Mar;14(3):287-94 [PMID: 22357576]
  44. N Engl J Med. 2021 Oct 14;385(16):1451-1461 [PMID: 34449189]
  45. ESC Heart Fail. 2024 Feb;11(1):315-326 [PMID: 38011017]
  46. J Card Fail. 2007 Aug;13(6):422-30 [PMID: 17675055]
  47. Exp Diabetes Res. 2012;2012:789325 [PMID: 21860616]
  48. PLoS Med. 2013 Oct;10(10):e1001531 [PMID: 24143138]
  49. J Card Fail. 2018 Jun;24(6):412-414 [PMID: 29548986]
  50. Clin J Am Soc Nephrol. 2011 Mar;6(3):528-36 [PMID: 21088286]
  51. J Hypertens. 2011 Sep;29(9):1829-36 [PMID: 21799444]
  52. Clin J Am Soc Nephrol. 2009 Sep;4(9):1477-1483 [PMID: 19713289]
  53. Circulation. 2018 Aug 28;138(9):861-870 [PMID: 29792299]
  54. J Am Coll Cardiol. 2006 May 16;47(10):1987-96 [PMID: 16697315]
  55. Heart. 2010 Apr;96(7):528-32 [PMID: 20350989]
  56. JAMA. 2019 Jul 9;322(2):113-114 [PMID: 31169890]
  57. Circ Heart Fail. 2012 Mar 1;5(2):144-51 [PMID: 22278404]
  58. N Engl J Med. 2006 Jul 20;355(3):251-9 [PMID: 16855265]
  59. Contrib Nephrol. 2013;182:174-94 [PMID: 23689662]
  60. Eur J Heart Fail. 2020 Aug;22(8):1342-1356 [PMID: 32483830]
  61. J Am Soc Nephrol. 2012 Oct;23(10):1725-34 [PMID: 22935481]

Grants

  1. 2013T084/Dutch Heart Foundation
  2. 2020B008 RECONNEXT/Dutch CardioVascular Alliance

MeSH Term

Male
United States
Humans
Female
Middle Aged
Heart Failure
Stroke Volume
Ventricular Function, Left
Prognosis
Ventricular Dysfunction, Left
Renal Insufficiency
Kidney

Word Cloud

Created with Highcharts 10.0.0dysfunctionkidneyparticipantsHFpEFmoderateventriculardiastolicfailuremildassociationleftheartpreservedejectionfraction95%confidence3higherparameterseGFRE/e'relativewallthicknessstageC/Dsexodds9eGFR:73 mnormalfunctionassociatedHeartAssociationAIMS:aiminvestigatewhethersex-specificMETHODSANDRESULTS:includedHELPFulobservationalstudyOutpatientclinicalcaredataincludingechocardiographyexpertpaneljudgementcollectedEstimatedglomerularfiltrationratecalculatedcreatininecystatinCwithoutracemassindextestedmultivariableadjustedregressionmodelsstratifiedreportingratiosintervalsintervalanalysed880meanage62standarddeviation:years69%femaleFourhundredsix376%60-89 mL/min/185%30-59 mL/min/1significantlyprevalent103%160%respectively4%lowervaluesParticipantslikelihoodAmericanCollegeCardiology/AmericanHFratio:207interval:12349functionsCONCLUSIONS:independentlyindependentstrongestConsideringmild-to-moderateriskfactormayhelpidentifyhigh-riskgroupsbenefitingearlyinterventionKidneyLeftRiskfactors

Similar Articles

Cited By